Jpmorgan Chase & CO Haemonetics Corp Transaction History

Jpmorgan Chase & CO

  • $1.27 Trillion
  • Q1 2025

A detailed history of Jpmorgan Chase & CO transactions in Haemonetics Corp stock. As of the latest transaction made, Jpmorgan Chase & CO holds 183,794 shares of HAE stock, worth $12.4 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
183,794
Previous 173,381 6.01%
Holding current value
$12.4 Million
Previous $13.5 Million 13.72%
% of portfolio
0.0%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 12, 2025
BUY
$59.34 - $80.05 $617,907 - $833,560
10,413 Added 6.01%
183,794 $11.7 Million
Q4 2024

Feb 12, 2025
BUY
$71.16 - $93.38 $1.33 Million - $1.74 Million
18,658 Added 12.06%
173,381 $13.5 Million
Q3 2024

Dec 26, 2024
SELL
$72.45 - $91.58 $151,855 - $191,951
-2,096 Reduced 1.34%
154,723 $12.4 Million
Q3 2024

Nov 08, 2024
SELL
$72.45 - $91.58 $151,855 - $191,951
-2,096 Reduced 1.34%
154,723 $12.4 Million
Q2 2024

Dec 26, 2024
BUY
$81.24 - $97.37 $170,279 - $204,087
2,096 Added 1.35%
156,819 $13 Million
Q2 2024

Aug 12, 2024
SELL
$81.24 - $97.37 $2.99 Million - $3.58 Million
-36,746 Reduced 18.98%
156,819 $13 Million
Q1 2024

Dec 26, 2024
BUY
$71.24 - $85.35 $2.77 Million - $3.32 Million
38,842 Added 25.1%
193,565 $16.5 Million
Q1 2024

May 10, 2024
BUY
$71.24 - $85.35 $1.23 Million - $1.47 Million
17,226 Added 9.77%
193,565 $16.5 Million
Q4 2023

Dec 26, 2024
BUY
$80.59 - $92.61 $1.74 Million - $2 Million
21,616 Added 13.97%
176,339 $15.1 Million
Q4 2023

Feb 12, 2024
BUY
$80.59 - $92.61 $399,887 - $459,530
4,962 Added 2.9%
176,339 $15.1 Million
Q3 2023

Nov 14, 2023
SELL
$82.56 - $93.49 $1.35 Million - $1.52 Million
-16,301 Reduced 8.69%
171,377 $15.4 Million
Q2 2023

Aug 11, 2023
BUY
$80.84 - $89.45 $791,181 - $875,447
9,787 Added 5.5%
187,678 $16 Million
Q1 2023

May 18, 2023
BUY
$72.75 - $90.6 $9.1 Million - $11.3 Million
125,116 Added 237.07%
177,891 $14.7 Million
Q1 2023

May 11, 2023
SELL
$72.75 - $90.6 $7.31 Million - $9.1 Million
-100,430 Reduced 65.55%
52,775 $4.37 Million
Q4 2022

Feb 13, 2023
BUY
$73.85 - $86.14 $498,635 - $581,617
6,752 Added 4.61%
153,205 $12 Million
Q3 2022

Nov 14, 2022
BUY
$63.3 - $78.66 $748,712 - $930,390
11,828 Added 8.79%
146,453 $10.8 Million
Q2 2022

Aug 11, 2022
SELL
$49.27 - $66.08 $22,368 - $30,000
-454 Reduced 0.34%
134,625 $8.77 Million
Q1 2022

May 11, 2022
BUY
$43.77 - $63.22 $1.14 Million - $1.64 Million
26,017 Added 23.86%
135,079 $8.54 Million
Q4 2021

Feb 10, 2022
SELL
$49.55 - $74.59 $202,709 - $305,147
-4,091 Reduced 3.62%
109,062 $5.78 Million
Q3 2021

Nov 12, 2021
BUY
$57.6 - $70.59 $6.52 Million - $7.99 Million
113,153 New
113,153 $7.99 Million

Others Institutions Holding HAE

# of Institutions
352
Shares Held
53.3M
Call Options Held
417K
Put Options Held
314K
View Full List

About HAEMONETICS CORP

HAE Quotes by TradingView
  • Ticker HAE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 51,316,500
  • Market Cap $3.47B
  • Description
  • Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...
More about HAE
Track This Portfolio

Track Jpmorgan Chase & CO Portfolio

Follow Jpmorgan Chase & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email